𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of Rituximab combined with THP-COP as first-line therapy for patients younger than 70

✍ Scribed by Takeshi Hara; Hisashi Tsurumi; Naoe Goto; Jun-ichi Kitagawa; Nobuhiro Kanemura; Takeshi Yoshikawa; Senji Kasahara; Hideko Goto; Kenji Fukuno; Toshiki Yamada; Michio Sawada; Ichiro Yasuda; Naoki Katsumura; Takeshi Takahashi; Tsuyoshi Takami; Hisataka Moriwaki

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
291 KB
Volume
136
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of a THP-COP regimen fo
A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma
✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly